NAD

NAD Inquiry of Tru NIAGEN Dietary Supplement Closes Without Review of Discontinued Product; Advertising Claims Permanently Discontinued

New York, NY – Jan. 9, 2020 – ChromaDex, Inc., the maker of Tru NIAGEN dietary supplement, has advised the National Advertising Division that the advertising claims at issue in a May 1, 2018 inquiry letter were permanently discontinued, and the 250 mg product then-advertised has not been marketed since late 2018, when a 300 mg product entered the market. NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. As part of NAD’s routine monitoring program, NAD requested substantiation...

Read More

NAD Recommends Discontinuation of Dramatization in TV Commercial for Sensodyne ProNamel Intensive Enamel Repair Toothpaste; Finds Other Claims Supported

New York, NY – December 19, 2019 – The National Advertising Division has recommended that GlaxoSmithKline Consumer Health discontinue a dramatization used in two television commercials for Sensodyne ProNamel Intensive Enamel Repair Toothpaste after determining that it reasonably conveyed to consumers the unsupported implied claim that ProNamel toothpaste fills and heals small, deep cracks on surface enamel. Further, NAD concluded that the claim that ProNamel toothpaste provides “next level” or “innovative” sodium fluoride technology was supported.  The claims were challenged by The...

Read More

NARB Upholds Advertising Claims for Crepe Erase Anti-Aging Body Care Treatment System

New York, NY – December 17, 2019 – A 5-person panel of the National Advertising Review Board (NARB) determined that Guthy-Renker LLC has supported certain express performance and ingredient claims, before-and-after photo comparisons, an expert opinion, and a celebrity endorsement for its Crepe Erase® Anti-Aging Body Care Treatment System.  The NARB panel also recommended that the advertiser make sure that all before-and-after photo comparisons illustrating the performance of Crepe Erase are accompanied by a clear and conspicuous disclosure indicating the duration of product use. The...

Read More

NAD Finds Verizon “First to 5G” Claim Supported, But Recommends Modification to Disclosure as Long as Service is More Unavailable Than Available

New York, NY – December 13, 2019 – The National Advertising Division determined that Verizon substantiated its “First to 5G” claim, however it recommended modification to the disclosures used to qualify the claim, as long as the service is more unavailable than available.  NAD also concluded that the advertising did not convey a message concerning the availability of 5G service on trains, but recommended that the advertiser discontinue the implied claim that Verizon’s 5G service can be used on a bus.  Finally, NAD recommended that, to the extent Verizon charges a fee for 5G service...

Read More

National Advertising Division Refers Advertising Claims Made by Zero Gravity to Federal Trade Commission and U.S. Food and Drug Administration

New York, NY – December 11, 2019 – The National Advertising Division has referred advertising claims made by Zero Gravity for its Perfectio line of medical devices to the Federal Trade Commission for further review. The advertiser did not respond to NAD’s requests to provide substantiation for its claims. NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. As part of NAD’s routine monitoring program, NAD requested substantiation for online advertising claims that included:...

Read More

NAD Finds Format of RXBAR Front Labels Not Misleading, Communicates Substantiated Claims about the Core Ingredients of an RXBAR

New York, NY – December 11, 2019 – The National Advertising Division has determined that the challenged claim, “3 Egg Whites / [Number][Nut/Legume] / 2 Dates / No B.S.,” as it appears in standardized format on the front label of RXBARs, communicates the supported message that those ingredients are in RXBARs, and does not reasonably convey misleading implied claims about weight and proportions of the protein bar inside. It also found that the claim “3 Egg Whites” was not misleading as to the form of egg whites in the bar. Both the challenger, KIND, LLC, and the advertiser, Insurgent Brands,...

Read More